Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin

Figure 1

Kaplan–Meier plots demonstrating progression-free survival (PFS) for the 20 patients in the study population (GOG 87M) compared to other single agent studies in the GOG protocol 87 series studying cytotoxic agents. Reprinted from [49], with permission from Elsevier.